An ad Substrate ARC: Autonomous Revenue Cycle is running — The creative as the library shows it, copied to our own storage.

Denials are the one leak big enough to move EBITDA, and most of what gets written off was…

Platform: LinkedIn
Format: Image
Countries: US
Category: B2B software
Read on: 29 August 2026

The copy, as stored

Denials are the one leak big enough to move EBITDA, and most of what gets written off was winnable. Substrate ARC works … The margin you're losing to denials

See it in the LinkedIn library Read the Substrate ARC: Autonomous Revenue Cycle competitor brief

Where Substrate ARC: Autonomous Revenue Cycle stands, from its brief

They position Substrate as an autonomous healthcare revenue-cycle system that recovers denied revenue and improves practice economics. Their ads rely on repeated proof points around denial leakage, fast deployment, hands-free work, and EBITDA impact. You can compete by making your mechanism, measurement rules, implementation effort, and human controls more explicit.

More from Substrate ARC: Autonomous Revenue Cycle

Every Substrate ARC: Autonomous Revenue Cycle ad

Seen the angle you want to answer?

Kamply builds the post or reel that answers it, on your brand's own tokens, with a brief first and a gate before anything is called done. Every ad on this wall was read into a competitor report; your reply to it is one brief away.

Download Kamply for Mac